Platelet Transfusion

Publication Date: November 28, 2017

Key Points

Key Points

Prophylactic platelet transfusion should be administered to patients with thrombocytopenia resulting from impaired bone marrow function to reduce the risk of hemorrhage when the platelet count falls below a predefined threshold level.

Recommended thresholds for prophylactic platelet transfusion are provided for patients with hematologic malignacies or solid tumors, and those undergoing hematopoietic stem cell transplantation or invasive procedures.

Guidance is also provided regarding the production of platelet products, prevention of Rh alloimmunization, and management of refractoriness to platelet transfusion.

Treatment

...atment

...Platelet ProductsPlatelets for tran...


...tion of Rh AlloimmunizationUPDATED. Prevention...


...oreductionUPDATED. The incidence of allo...


...s Therapeutic Platelet TransfusionProp...


...elet Transfusion Threshold in Patients with...


...sion Threshold in the Setting of Hemato...


...elet Transfusion in Patients with Ch...


...let Transfusion Threshold in Patien...


...et Count at which Surgical or Invasiv...


...ing for Refractoriness to Platelet Trans...


...ractoriness to Platelet TransfusionA...